![]() |
市場調査レポート
商品コード
1316288
医療機器向け3Dプリンティングの世界市場-2023年~2030年Global Medical Device 3D Printing Market - 2023-2030 |
||||||
カスタマイズ可能
適宜更新あり
|
医療機器向け3Dプリンティングの世界市場-2023年~2030年 |
出版日: 2023年07月27日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
|
世界の医療機器向け3Dプリンティング市場は、2022年に26億米ドルに達し、2030年には79億米ドルに達するなど、有利な成長が予測されています。世界の医療機器向け3Dプリンティング市場は、予測期間中(2023~2030年)に15.7%のCAGRを示すと予測されています。
義肢や装具の製造は、3Dプリンティングによって一変しました。この技術により、軽量で正確にフィットし、ユーザーにとってより快適で有用な器具の作成が可能になっています。
外科医は、3Dプリンティングを使用して、患者ごとに固有の手術ガイダンスや器具を作ることができます。これらのマニュアルは、手術結果の向上、手術リスクの低減、正確な術前準備に役立ちます。さらに、特定の外科手術のニーズを満たすために特別なツールを作成することもできます。
2023年6月、医療機器製造分野で事業を展開するEOS、Precision ADM、Orthopaedic Innovation Centre(OIC)、Tecometの4社が協力関係を構築しました。この提携により、医療機器向け積層造形(AM)のための包括的なソリューションが提供されます。
医療機器向けAMの製造を拡大するには、プリンティングにとどまらず、設計、後処理、検査、滅菌、包装などを含むプロセスチェーン全体を十分に理解する必要があります。Tecomet、OIC、Precision ADMとの協業により、積層造形における比類なき経験が得られ、医療機器メーカーが規制環境の難関を乗り切り、高品質で信頼できる製品を供給できるよう支援します。
3D Printing in Medicineに掲載された記事によると、2022年には、すでに存在する医療機器規則を通じて、米国食品医薬品局(FDA)が3Dプリンティング機器を管理します。しかし、3Dプリンティングはヘルスケア業界全体に急速に広がっているため、FDAはポイントオブケア(PoC)3Dプリンティングに特化した基準や規制を策定することにますます関心を寄せています。
ポイントオブケア(PoC)医療機器の製造は、最近の3Dプリンテッド医療機器研究の発展により急速に増加しています。PoC 3Dプリンティングは、患者の転帰を向上させ、手術室の時間と費用を削減する可能性を秘めているにもかかわらず、このような設計および製造環境は、医療機器メーカーと治療の提供者の区別を曖昧にし、規制上の不確実性を高めています。
COVID-19の流行は、医療機器向け3Dプリンティング市場に大きな影響を与えました。COVID-19検査規制の結果、検査キットと診断ツールの需要が急増しました。検査キットや診断ツールの一部として、鼻咽頭スワブやサンプル採取容器が3Dプリンティングで製造されました。3Dプリンティングを活用することで、これらのコンポーネントを迅速にプロトタイプ化して生産することが可能になり、増大する需要を満たすことができました。
ロシア・ウクライナ紛争が医療機器向け3Dプリンティング市場に与える影響は複雑で多面的です。政府とヘルスケアシステムは、紛争時には緊急時の備え、インフラ、必要不可欠なヘルスケアの要件を優先する可能性があります。医療機器向け3Dプリンティングのような最先端技術の受容と投資は、このような優先順位と資源配分の変化によって影響を受ける可能性があります。より緊急で差し迫った需要に資金が回され、注目が集まるかもしれないです。
The global medical device 3D printing market reached US$ 2.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 7.9 billion by 2030. The global medical device 3D printing market is expected to exhibit a CAGR of 15.7% during the forecast period (2023-2030).
The manufacturing of artificial limbs and orthotic devices has been transformed by 3D printing. The technique makes it possible to create lightweight, precisely fitting devices that are comfier and useful for the user.
Surgeons can use 3D printing to make surgical guidance and equipment that are unique to each patient. These manuals help to improve surgical outcomes, lower surgical risks, and aid in precise pre-operative preparation. Additionally, special tools might be created to meet certain surgical needs.
In June 2023, EOS, Precision ADM, Orthopaedic Innovation Centre (OIC), and Tecomet, four companies operating in the medical device manufacturing sector, established cooperation. An all-inclusive solution for the additive manufacture of medical devices will be offered by this cooperation.
Scaling up the manufacturing of AM medical devices necessitates a thorough understanding of the entire process chain, which goes beyond printing and includes, among other things, design, post-processing, testing, sterilization, and packaging. Incomparable experience in additive manufacturing will result from our collaboration with Tecomet, OIC, and Precision ADM, which will assist medical device manufacturers in navigating the difficulties of the regulatory environment and supplying high-quality, dependable goods.
As per the article published in 3D Printing in Medicine, in 2022, through already-existing medical device rules, the Food & Drug Administration (FDA) of the United States controls 3D-printed devices. However, because 3D printing is spreading quickly throughout the healthcare industry, the FDA is becoming more and more interested in creating standards and regulations specifically for point-of-care (PoC) 3D printing.
Manufacturing of point-of-care (PoC) medical devices has rapidly increased as a result of recent developments in 3D-printed medical device research. Despite the fact that PoC 3D printing has the potential to enhance patient outcomes and cut down on operating room time and expenses, such a design and production environment blurs the distinction between medical device manufacturers and providers of treatment and raises regulatory uncertainty.
The COVID-19 pandemic has had a significant impact on the medical device 3D printing market. The demand for testing kits and diagnostic tools surged as a result of the COVID-19 testing regulations. Nasopharyngeal swabs and sample-collecting containers were produced using 3D printing as part of testing kits and diagnostic tools. Utilizing 3D printing, it was possible to quickly prototype and produce these components, helping to satisfy the growing demand.
The impact of the Russia-Ukraine war on the medical device 3D printing market is complex and multifaceted. Governments and healthcare systems may prioritize emergency preparedness, infrastructure, and essential healthcare requirements during times of conflict. The acceptance and investment in cutting-edge technologies like 3D printing for medical devices could be impacted by this change in priorities and resource allocation. More urgent and immediate demands may receive funding and attention.
The global medical device 3D printing market is segmented based on product, technology, application, end-user, and region.
The electron beam melting segment accounted for the highest market stake accounting for approximately 36.1% of the medical device 3D printing market in 2022. In the 3D manufacturing technique known as electron beam melting (EBM), a high-energy electron beam melts a metal powder. An object that precisely matches the criteria specified by a CAD model is created by melting multiple layers of powdered metal under the control of an electron beam, which generates an electron stream that is guided by a magnetic field.
In order to protect highly reactive materials from oxidation, production is done in a vacuum chamber. Similar to Selective Laser Melting (SLM), Electron Beam Melting (EBM) prints from a powder from the powder bed of the 3D printer, but EBM utilizes an electron beam as opposed to a laser.
North America is expected to dominate the Medical Device 3D Printing market, accounting for around 38.7% of this market. In March 2023, with a collaboration with 3D Systems, the manufacturer of medical devices Paragon Medical is investing in additive manufacturing capabilities. According to reports, the new cooperation will make use of the historical knowledge and competencies that both institutions can offer to clients.
The collaboration between the companies covers material procurement and supply, part design and process development, machine onboarding and validation, and regulatory assistance. The partnership between 3D Systems and Paragon Medical will enable them to grow the production of medical devices using cutting-edge metal and plastic 3D printing technology.
The major global players in the market include: Stratasys Ltd., EnvisionTEC, Koninklijke Philips N.V., 3D Systems, Inc., EOS, Renishaw plc, Materialise, 3T Additive Manufacturing Ltd., General Electric Company, Carbon, Inc., and Prodways Group among others.
The global medical device 3D printing market report would provide approximately 69 tables, 72 figures, and 195 Pages.
LIST NOT EXHAUSTIVE